Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Probable ATP-dependent RNA helicase DHX37 (DHX37) is an enzyme belonging to the DEAH-box family of RNA helicases, characterized by conserved ATPase and RNA-binding domains. Its primary function is to facilitate the maturation of the small ribosomal subunit by catalyzing the unwinding of RNA secondary structures and the removal of U3 snoRNP from preribosomal particles during ribosome biogenesis. DHX37 contains a canonical DEAH ATPase/helicase core and a unique carboxy-terminal domain required for interaction with regulatory proteins such as UTP14A. It is expressed broadly, with crucial roles in early testis and brain development, and has been implicated in genetic diseases related to developmental anomalies and certain cancers. Disruption or mutation of DHX37 is associated with syndromes such as 46,XY sex reversal and neurodevelopmental disorders with brain anomalies[1][5][6][2].
ATP-dependent unwinding of RNA during ribosome assembly and pre-rRNA processing
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Probable ATP-dependent RNA helicase DHX37 (DHX37).